Northwestern Mutual Wealth Management
RNTX

Northwestern Mutual Wealth Management’s Rein Therapeutics RNTX Stock Holding History

Northwestern Mutual Wealth Management’s Portfolio RNTX Stock Details RNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$44.1K Hold
42,440
– – ﹤0.01% 2590
2026
Q1 		$55.2K Hold
42,440
– – ﹤0.01% 2400
2025
Q4 		$49.2K Hold
42,440
– – ﹤0.01% 2405
2025
Q3 		$48.6K Sell
42,440
-6,222
-13% -$7.9K ﹤0.01% 2331
2025
Q2 		$68.1K Buy
48,662
+33,221
+215% +$59.8K ﹤0.01% 2139
2025
Q1 		$27.3K Buy
+15,441
New +$32.4K ﹤0.01% 2398

Other funds holding RNTX

VC
Voss Capital Houston, Texas $2.15B AUM 33.46% 1-Year Est. Return
CCC
Cable Car Capital San Francisco, California $4.66B AUM 77.16% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BCM
BIOS Capital Management Fort Worth, Texas $41.7M AUM 34.92% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $164M AUM 542.31% 1-Year Est. Return
SM
Senvest Management New York $3.41B AUM 66.27% 1-Year Est. Return

Northwestern Mutual Wealth Management's RNTX Position: Q2 2026 in Review

Northwestern Mutual Wealth Management held its Rein Therapeutics (RNTX) position steady in Q2 2026 at 42,440 shares worth $44.1K. The position accounts for ﹤0.01% of the portfolio, ranked #2590.

Northwestern Mutual Wealth Management first reported a position in RNTX in Q1 2025 and has held it in 6 quarters since. The position peaked at $68.1K in Q2 2025. 60 funds tracked by Wall St. Rank hold RNTX as of Q2 2026.

  • Northwestern Mutual Wealth Management held 42,440 shares of Rein Therapeutics worth $44.1K as of Q2 2026.
  • Northwestern Mutual Wealth Management left its Rein Therapeutics share count unchanged in Q2 2026.
  • Rein Therapeutics made up ﹤0.01% of Northwestern Mutual Wealth Management's portfolio in Q2 2026, its #2590 holding.
  • Northwestern Mutual Wealth Management first reported a position in Rein Therapeutics in Q1 2025 and has held it in 6 quarters since.
  • Northwestern Mutual Wealth Management's Rein Therapeutics position peaked at $68.1K in Q2 2025.
  • 60 funds tracked by Wall St. Rank held Rein Therapeutics as of Q2 2026.

Based on Northwestern Mutual Wealth Management's 13F filing for Q2 2026, filed 12 Aug 2026.